Moneycontrol
SENSEX NIFTY
you are here:

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals

BSE Live

Jul 08, 16:00
419.40 2.90 (0.70%)
Volume
AVERAGE VOLUME
5-Day
665,157
10-Day
850,888
30-Day
736,915
230,200
  • Prev. Close

    416.50

  • Open Price

    414.00

414.00

Today’s L/H

425.25
168.00

52 Wk L/H

572.70
374.85

L/U Price Band

458.15
  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP

    421.10
     Beta
    0.70
  • Market Depth (08 Jul 2020)

    BUYSELL
    QTY PRICE PRICE QTY
    25 420.50 421.00 89
    503 420.00 421.45 450
    100 419.90 421.55 250
    110 419.85 421.60 160
    127 419.80 421.65 120
    0 Total Total 0
     Market Depth
    BUY 0
    SELL 0
    0%
    0%

NSE Live

Jul 08, 15:59
419.35 2.85 (0.68%)
Volume
AVERAGE VOLUME
5-Day
7,593,914
10-Day
11,633,292
30-Day
11,799,922
3,660,105
  • Prev. Close

    416.50

  • Open Price

    415.50

415.15

Today’s L/H

425.00
161.65

52 Wk L/H

573.05
374.85

L/U Price Band

458.15
  • Bid Price (Qty.)

    419.35 (8504)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP

    421.46
     Beta
    0.75
  • DELIVERY AVERAGES
    3-Day
    0%
    5-Day
    0%
    8-Day
    0%
    Deliverables
    0%
  • SMA
    30
    417.04
    50
    385.31
    150
    331.41
    200
    328.41
    SMA
    417.04
Powered by Trendlyne
Parameters
NSE
BSE
Bid Price
419.35
0.00
Bid Qty
8504
0
Offer Price
0.00
0.00
Offer Qty
0
0
Today's Low
415.15
414.00
Today's High
425.00
425.25
52 Wk Low
161.65
168.00
52 Wk High
573.05
572.70
Open Price
415.50
414.00
Prev. Close
416.50
416.50
Expiry Date
428.00 6.50 ( 1.54 % )
Parameters
NSE
Open Price
423.35
High Price
428.00
Low Price
419.00
Prev. Close
421.50
Average Price
424.58
No. of Contracts Traded
56
Turnover (Rs. In Lakhs)
546.86
Market Lot
2300
Open Interest
5,126,700
Open Interest Change
-66,700
Open Interest Change %
-1.28
Expiry Date
Option Type
Strike Price
428.00 6.50 ( 1.54 % )
Parameters
NSE
Open Price
423.35
High Price
428.00
Low Price
419.00
Prev. Close
421.50
Average Price
424.58
No. of Contracts Traded
56
Turnover (Rs. In Lakhs)
546.86
Market Lot
2300
Open Interest
5,126,700
Open Interest Change
-66,700
Open Interest Change %
-1.28

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

TECHNICAL ANALYSIS

TECHNICAL RATING
Neutral
Moving Averages Neutral
Technical Indicators Neutral
Moving Averages Crossovers Neutral
Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 424.00 431.50 436.00 419.50 412.00 407.50 400.00
Fibonacci 424.08 426.92 431.50 419.50 414.92 412.08 407.50
Camarilla 417.60 418.70 419.80 419.50 415.40 414.30 413.20

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

SIMPLE MOVING AVERAGES
Days NSE
5 426.36
10 440.99
20 433.21
50 385.31
100 327.50
200 328.41
Pivot levels

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 470.30 507.90 531.10 447.10 409.50 386.30 348.70
Fibonacci 470.33 484.67 507.90 447.10 423.87 409.53 386.30
Camarilla 438.27 443.85 449.42 447.10 427.13 421.55 415.98

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 563.48 676.67 780.28 459.87 346.68 243.07 129.88
Fibonacci 542.68 593.85 676.67 459.87 377.05 325.88 243.07
Camarilla 470.17 490.05 509.92 459.87 430.43 410.55 390.68

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Valuation

    • Market Cap (Rs Cr.)
      11,834.13
    • P/E
      8.73
    • Book Value (Rs)
      468.74
    • Dividend (%)
      250.00
    • Market Lot
      1
    • Industry P/E
      31.02
    • EPS (TTM)
      48.01
    • P/C
      7.93
    • Price/Book
      0.89
    • Dividend Yield.(%)
      0.60
    • Face Value (RS)
      1.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      0
      5-Day
      0
      8-Day
      0
      29.68

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      11,834.13
    • P/E
      15.25
    • Book Value (Rs)
      215.12
    • Dividend (%)
      250.00
    • Market Lot
      1
    • Industry P/E
      31.02
    • EPS (TTM)
      27.5
    • P/C
      9.92
    • Price/Book
      1.95
    • Dividend Yield.(%)
      0.60
    • Face Value (RS)
      1.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      0
      5-Day
      0
      8-Day
      0
      29.68

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

F&O QUOTE

NSE 428.00 6.50 (1.54%)
Instrument Type
Expiry Date
Option Type
Strike Price
    • Open Price
      423.35
    • High Price
      428.00
    • Low Price
      419.00
    • Prev. Close
      421.50
    • Average Price
      424.58
    • No. of Contracts Traded
      56
    • Turnover (Rs. In Lakhs)
      546.86
    • Market Lot
      2300

Forum

Community Sentiments

  • 71% BUY
  • 23% SELL
  • 6% HOLD
71%
of moneycontrol users recommend buying Glenmark

What's your call on Glenmark today?

Read 86 investor views

BUY SELL HOLD

Action in Glenmark Pharma Ltd.

Pre-Opening Session Prices9:00 am - 9:15 am

BSE

Jul 08, 09:15
414.00 -2.50 (-0.60%)
High 414.00
Low 411.00
Prev. Close 416.50

NSE

Jul 08, 09:15
415.50 -1.00 (-0.24%)
High 415.90
Low 415.50
Prev. Close 416.50

Financials

(Rs. Cr)
Quarterly MAR 2020 DEC 2019 SEP 2019 JUN 2019 MAR 2019
Sales
2,767.49 2,735.56 2,815.04 2,322.88 2,563.47
Other Income
44.15 32.96 80.83 1.67 39.06
Total Income
2,811.64 2,768.52 2,895.87 2,324.55 2,602.53
Total Expenditure
2,395.20 2,401.49 2,458.79 2,071.71 2,280.32
EBIT
416.43 367.04 437.07 252.85 322.22
Interest
98.47 96.06 89.77 93.02 81.91
Tax
97.65 80.14 91.76 50.55 78.65
Net Profit
220.31 190.84 255.54 109.28 161.66

Historical Prices

On
Current Price %Gain / Loss
Open Price 429.00 414.00
-3.5
High Price 440.00 425.25
-3.35
Low Price 423.70 414.00
-2.29
Close Price 436.75 416.50
-4.64
Volume 66,738 230,200
244.93
On
Current Price %Gain / Loss
Open Price 429.00 415.50
-3.15
High Price 438.80 425.00
-3.14
Low Price 423.65 415.15
-2.01
Close Price 436.55 416.50
-4.59
Volume 932,003 3,660,105
292.71
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 10705.80 -93.90 -0.87
SENSEX 36329.01 -345.51 -0.94
NIFTY BANK 22584.70 -43.30 -0.19
NIFTY IT 15513.70 -271.30 -1.72
S&P BSE Smallcap 12785.13 -54.64 -0.43
Index Price Change %Chg
CAC (Jul 08) 4,989.94 -53.79 -1.07
DAX (Jul 08) 12,525.48 -91.32 -0.72
FTSE (Jul 08) 6,161.28 -28.62 -0.46
Nasdaq (Jul 08) 10,459.52 115.63 1.12
SGX Nifty (Jul 08) 10,687.50 4.00 0.04

CORPORATE ACTION

Date Agenda
Jun 26, 2020 Audited Results & Dividend
Feb 14, 2020 Quarterly Results & Others
Nov 14, 2019 Quarterly Results
Aug 13, 2019 Quarterly Results
Type Dividend% Ex-Dividend date
Final 200.00 Sep 19, 2019
Final 200.00 Sep 19, 2018
Final 200.00 Sep 20, 2017
Final 200.00 Aug 03, 2016
Final 200.00 Sep 10, 2015
Ratio Announcement Date Ex-Bonus
1:1 Jan 06, 2005 Mar 04, 2005
Old FV New FV Ex-Split
2 1 Sep 10, 2007
10 2 Oct 23, 2003
Ratio Premium Ex-Bonus
No Rights Information is available for Glenmark Pharma
Date Agenda
Sep 27, 2019 -
Sep 27, 2018 -
Sep 28, 2018 -
Sep 29, 2017 -
Aug 12, 2016 Rs.2.0000 per share(200%)Dividend

Dividend Summary

For the year ending March 2020 Glenmark Pharma has declared an equity dividend of 250.00% amounting to Rs 2.5 per share. At the current share price of Rs 419.35 this results in a dividend yield of 0.6%.

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone March 2020 December 2019 June 2019 December 2018
Promoters 46.62 46.59 46.58 46.54
Pledged 0 0 0 0
FII/FPI 28.51 30.16 31.04 32.27
Total DII 11.8 11.72 13.05 11.85
Fin.Insts 2.99 2.97 2.62 2.72
Insurance Co 0 0 0 0
MF 3.74 4.07 4.88 4.02
Others DIIs 5.07 4.68 5.55 5.11
Others 13.06 11.53 9.35 9.34
Total 99.99 100 100.02 100

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Glenmark 419.40 0.70 572.70 168.00 11834.13 6,712.63 1,354.55
Sun Pharma 484.00 0.95 512.55 315.20 116127.81 12,531.93 3,211.14
Dr Reddys Labs 3885.85 1.65 4189.35 2352.00 64595.46 11,850.40 2,937.70
Divis Labs 2164.25 -0.90 2537.70 1466.95 57454.04 5,310.57 1,372.71
Cipla 634.45 -0.31 696.00 356.75 51153.86 12,659.15 2,318.17

COMPANY OVERVIEW

Glenmark Pharmaceuticals Ltd has a significant presence in the branded generics markets across emerging economies including India.The company entered into the dermatology market through the launch of its Candid Cream.Glenmarks ground-breaking drug discovery effort is primarily focused in the areas of inflammation [asthma/COPD, rheumatoid arthritis etc.], metabolic disorders [diabetes, obesity, etc.] and pain [neuropathic pain and inflammatory pain].The formulations business of the company focuses on therapeutic areas viz. dermatology, anti-infective, respiratory, cardiac, diabetes, gynecology, CNS, and oncology. India is the largest market in terms of revenue for the organization.

COMPANY INFORMATION

  • Registered Office

  • Registrars

    • Name

      Karvy Computershare Private Ltd.

    • Address

      Plot no. 31-32, GachibowliFinancial DistrictNanakramguda

    • City

      Hyderabad 500032

    • State

      Telangana

    • Tel. No.

      040-23001153

    • Fax No.

    • Email

    • Internet

  • Management

    • Name

      Designation

    • Glenn Saldanha

      Chairman & Managing Director

    • V S Mani

      Executive Director & Global CFO

    • Rajesh V Desai

      Non Executive Director

    • B E Saldanha

      Non Executive Director

    • Bernard Munos

      Ind. Non-Executive Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      Yes

    • Bse-200

      Yes

    • S&P CNX 500

      Yes

    • CNX Midcap

      Yes

About Glenmark Pharma Ltd.

Glenmark is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 532296 and the NSE with an NSE Code of GLENMARK.

Related Searches